Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
Growth hormone-releasing peptides (GHRPs) can increase protein synthesis and reduce muscle damage
While anyone can benefit from vitamin B12s energy-boosting properties, certain groups are particularly at risk of deficiency and may find these injections invaluable
BPC-157 ulcerative colitis: what the research says BPC-157 is a small peptide first described in gastric juice
The pathway diagrams made complex processes easy to grasp, and the gene specific supplement advice was spot on
This scientific identification does not establish safety, efficacy or suitability for any medical, diagnostic, consumer or veterinary application